Nokia Corporation (ADR) (NYSE:NOK) may be an afterthought to some in the smartphone market. This is not for a lack of effort. This is not because the company has abandoned this market for the time being. It is simply because it has lost market share in North America over the years. Nokia Corporation (ADR) (NYSE:NOK)…
JPMorgan Chase & Co. (NYSE:JPM) EVP Gordon Smith sold 71,952 shares of the stock in a transaction that occurred on Monday, April 14th. The stock was sold at an average price of $54.91, for a total value of $3,950,884.32. Following the transaction, the executive vice president now directly owns 143,905 shares of the company’s stock,…
Google co-operates with Boston Dynamics, who is a creator of several electronic entities. But what is the aim of software giant?Read More >>
CERN is one of the most mysterious “brain centers” of the world. What is going behind the scenes and who are the faces behind researches such as Higgs Boson?Read More >>
Our personal data are more valuable than ever before. With the spread of technologies of big data analysis, the number of cyber attacks on citizen's computer's is growing. What to do against hacking and how to protect our digital entities?Read More >>
Some drugs that have gained approval this year so far include AstraZeneca’s Myalept (complications of leptin deficiency) and Farxiga (type II diabetes), Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) (to treat neurogenic orthostatic hypotension), BioMarin’s Vimizim (Morquio A syndrome) and Vanda Pharma’s Hetlioz. Chelsea Therapeutics International Ltd. (NASDAQ:CHTP) stock performance was -5.75% in last session and finished…
